More Topics:
VirtualScopics Regains Nasdaq Compliance
Posted February 9, 2012
We Recommend...
ROCHESTER, N.Y., -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of quantitative imaging for clinical trials, today announced that it has received notification from The Nasdaq Stock Market that it has regained compliance with the minimum $1.00 per share bid price requirement, and further, that it currently complies with all other applicable standards for continued listing.
To regain compliance with the bid price rule, the Company was required to evidence a closing bid price of $1.00 per share or more for a period of at least 10 consecutive trading days. On February 8, 2012, the closing bid price of the Company's common stock was greater than $1.00 per share, the tenth consecutive day the stock price had a closing bid price above $1.00 per share.
Accordingly, the Company has regained compliance with Listing Rule 5550(a)(2) and have been notified by Nasdaq that this matter is now closed.
About VirtualScopics, Inc.
VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate drug and medical device development. VirtualScopics has developed a robust software platform for analysis and modeling of both structural and functional medical images. In combination with VirtualScopics' industry-leading experience and expertise in advanced imaging biomarker measurement, this platform provides a uniquely clear window into the biological activity of drugs and devices in clinical trial patients, allowing sponsors to make better decisions faster. For more information about VirtualScopics, visit www.virtualscopics.com.
To find out more about the company in this article and to see if you
have business connections, click below:
blog comments powered by